Cargando…

EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review

BACKGROUND: Limited effectiveness of therapeutic agents targeting epidermal growth factor receptor (EGFR) in clinical trials using unselected ovarian cancer patients has prompted efforts to more effectively stratify patients who might best benefit from these therapies. A series of studies that have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mehner, Christine, Oberg, Ann L., Goergen, Krista M., Kalli, Kimberly R., Maurer, Matthew J., Nassar, Aziza, Goode, Ellen L., Keeney, Gary L., Jatoi, Aminah, Radisky, Derek C., Radisky, Evette S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511892/ https://www.ncbi.nlm.nih.gov/pubmed/28740577 http://dx.doi.org/10.18632/genesandcancer.142

Ejemplares similares

Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers
por: Mehner, Christine, et al.
Publicado: (2015)

Tumor cell expression of MMP3 as a prognostic factor for poor survival in pancreatic, pulmonary, and mammary carcinoma
por: Mehner, Christine, et al.
Publicado: (2015)

Targeting an autocrine IL-6 – SPINK1 signaling axis to suppress metastatic spread in ovarian clear cell carcinoma
por: Mehner, Christine, et al.
Publicado: (2020)

Activity-based protein profiling reveals active serine proteases that drive malignancy of human ovarian clear cell carcinoma
por: Mehner, Christine, et al.
Publicado: (2022)

Bad Tumors Made Worse: SPINK1
por: Mehner, Christine, et al.
Publicado: (2019)

Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer
por: Mehner, Christine, et al.
Publicado: (2014)

PEGylation Extends Circulation Half-Life While Preserving In Vitro and In Vivo Activity of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1)
por: Batra, Jyotica, et al.
Publicado: (2012)

PRSS3/Mesotrypsin and kallikrein-related peptidase 5 are associated with poor prognosis and contribute to tumor cell invasion and growth in lung adenocarcinoma
por: Ma, Honghai, et al.
Publicado: (2019)

Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast Cancer
por: Radisky, Evette S., et al.
Publicado: (2010)

Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic
por: Hendrickson, Andrea Wahner, et al.
Publicado: (2015)

Matrix Metalloproteinase-10/TIMP-2 Structure and Analyses Define Conserved Core Interactions and Diverse Exosite Interactions in MMP/TIMP Complexes
por: Batra, Jyotica, et al.
Publicado: (2013)

Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer
por: Radisky, Evette S., et al.
Publicado: (2017)

Mirolysin structures open a window on gum disease
por: Radisky, Evette S.
Publicado: (2020)

Prior oral contraceptive use in ovarian cancer patients: assessing associations with overall and progression-free survival
por: Jatoi, Aminah, et al.
Publicado: (2015)

MYC Suppresses Cancer Metastasis by Direct Transcriptional Silencing of αv and β3 Integrin Subunits
por: Liu, Hong, et al.
Publicado: (2012)

Combinatorial engineering of N-TIMP2 variants that selectively inhibit MMP9 and MMP14 function in the cell
por: Arkadash, Valeria, et al.
Publicado: (2018)

The Ratios of CD8(+) T Cells to CD4(+)CD25(+) FOXP3(+) and FOXP3(-) T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer
por: Preston, Claudia C., et al.
Publicado: (2013)

Engineering of tissue inhibitor of metalloproteinases TIMP-1 for fine discrimination between closely related stromelysins MMP-3 and MMP-10
por: Raeeszadeh-Sarmazdeh, Maryam, et al.
Publicado: (2022)

miR-200c at the nexus of epithelial-mesenchymal transition, resistance to apoptosis, and the breast cancer stem cell phenotype
por: Radisky, Derek C
Publicado: (2011)

Mapping protein selectivity landscapes using multi-target selective screening and next-generation sequencing of combinatorial libraries
por: Naftaly, Si, et al.
Publicado: (2018)

93rd Annual Meeting of the American Association for Cancer Research, San Francisco, CA, USA, 6-10 April 2002
por: Novaro, Virginia, et al.
Publicado: (2002)

Small molecule inhibitors of mesotrypsin from a structure-based docking screen
por: Kayode, Olumide, et al.
Publicado: (2017)

Gene signature model for breast cancer risk prediction for women with sclerosing adenosis
por: Degnim, Amy C., et al.
Publicado: (2015)

Tyrosine Sulfation of Human Trypsin Steers S2’ Subsite Selectivity towards Basic Amino Acids
por: Szabó, András, et al.
Publicado: (2014)

Avidity observed between a bivalent inhibitor and an enzyme monomer with a single active site
por: Lacham-Hartman, Shiran, et al.
Publicado: (2021)

CHFR and Paclitaxel Sensitivity of Ovarian Cancer
por: Wahner Hendrickson, Andrea E., et al.
Publicado: (2021)

Mammary Involution and Breast Cancer Risk: Transgenic Models and Clinical Studies
por: Radisky, Derek C., et al.
Publicado: (2009)

ROS-induced epithelial-mesenchymal transition in mammary epithelial cells is mediated by NF-κB-dependent activation of Snail
por: Cichon, Magdalena A., et al.
Publicado: (2014)

Cutting the brakes and flooring the gas: how TMEPAI turns TGF-β into a tumor promoter
por: Cichon, Magdalena A., et al.
Publicado: (2014)

Regulation of mechanical stress by mammary epithelial tissue structure controls breast cancer cell invasion
por: Radisky, Derek C., et al.
Publicado: (2013)

Extracellular matrix as a contextual determinant of transforming growth factor-β signaling in epithelial-mesenchymal transition and in cancer
por: Cichon, Magdalena A, et al.
Publicado: (2014)

Inflammation, Infiltration, and Evasion—Tumor Promotion in the Aging Breast
por: Cruz-Reyes, Nicole, et al.
Publicado: (2023)

Climbing Up and Down Binding Landscapes through Deep Mutational Scanning of Three Homologous Protein–Protein Complexes
por: Heyne, Michael, et al.
Publicado: (2021)

Toward understanding the genetics of regulatory T cells in ovarian cancer
por: DeRycke, Melissa S, et al.
Publicado: (2013)

Expression signature distinguishing two tumour transcriptome classes associated with progression-free survival among rare histological types of epithelial ovarian cancer
por: Wang, Chen, et al.
Publicado: (2016)

356 Upregulated Genes in Age-Related Lobular Involution Stagnation Represent Potential Biomarkers That Link To Increased Breast Cancer Risk
por: Radisky, Derek, et al.
Publicado: (2023)

Sclerosing adenosis and risk of breast cancer
por: Visscher, Daniel W., et al.
Publicado: (2014)

Pemetrexed for Ovarian Cancer: A Systematic Review of the Published Literature and a Consecutive Series of Patients Treated in a Nonclinical Trial Setting
por: Egloff, Heidi, et al.
Publicado: (2014)

Novel Pathogenic PRSS1 Variant p.Glu190Lys in a Case of Chronic Pancreatitis
por: Jancsó, Zsanett, et al.
Publicado: (2019)

FAM111A protects replication forks from protein obstacles via its trypsin-like domain
por: Kojima, Yusuke, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d6u4104klsdmqrluicpkgmjc3e